BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 17134780)

  • 1. Neurokinin-1 and neurokinin-3 receptors in primate substantia nigra.
    Lévesque M; Wallman MJ; Parent R; Sík A; Parent A
    Neurosci Res; 2007 Mar; 57(3):362-71. PubMed ID: 17134780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and subcellular localization of neurokinin-1 and neurokinin-3 receptors in primate globus pallidus.
    Lévesque M; Parent R; Parent A
    Eur J Neurosci; 2006 May; 23(10):2760-72. PubMed ID: 16817879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominant surface distribution of neurokinin-3 receptors in non-dopaminergic dendrites in the rat substantia nigra and ventral tegmental area.
    Lessard A; Grady EF; Bunnett NW; Pickel VM
    Neuroscience; 2007 Feb; 144(4):1393-408. PubMed ID: 17197098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An electron microscope immunocytochemical study of GABA(B) R2 receptors in the monkey basal ganglia: a comparative analysis with GABA(B) R1 receptor distribution.
    Charara A; Galvan A; Kuwajima M; Hall RA; Smith Y
    J Comp Neurol; 2004 Aug; 476(1):65-79. PubMed ID: 15236467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The subcellular localization of GABA(B) receptor subunits in the rat substantia nigra.
    Boyes J; Bolam JP
    Eur J Neurosci; 2003 Dec; 18(12):3279-93. PubMed ID: 14686901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential co-localization of neurokinin-3 receptor and NMDA/AMPA receptor subunits in neurons of the substantia nigra of C57/BL mice.
    Wang YQ; Hu HJ; Cao R; Chen LW
    Brain Res; 2005 Aug; 1053(1-2):207-12. PubMed ID: 16038885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABAergic control of substantia nigra dopaminergic neurons.
    Tepper JM; Lee CR
    Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
    Lavoute C; Weiss M; Rostain JC
    Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological evidence for GABA/glycine-cocontaining terminals in synaptic contact with neurokinin-1 receptor-expressing neurons in the sacral dorsal commissural nucleus of the rat.
    Feng YP; Li YQ; Wang W; Wu SX; Chen T; Shigemoto R; Mizuno N
    Neurosci Lett; 2005 Nov; 388(3):144-8. PubMed ID: 16043285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra.
    Hersch SM; Yi H; Heilman CJ; Edwards RH; Levey AI
    J Comp Neurol; 1997 Nov; 388(2):211-27. PubMed ID: 9368838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide co-release with GABA may explain functional non-monotonic uncertainty responses in dopamine neurons.
    Tan CO; Bullock D
    Neurosci Lett; 2008 Jan; 430(3):218-23. PubMed ID: 18053647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
    Lavoute C; Weiss M; Rostain JC
    Brain Res; 2007 Oct; 1176():37-44. PubMed ID: 17900538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular distribution and plasticity of neurokinin-1 receptors in the rat substantia nigra and ventral tegmental area.
    Lessard A; Pickel VM
    Neuroscience; 2005; 135(4):1309-23. PubMed ID: 16165296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunohistochemical study on a unique colocalization relationship between substance P and GABA in the central nucleus of amygdala.
    Shigematsu N; Yamamoto K; Higuchi S; Fukuda T
    Brain Res; 2008 Mar; 1198():55-67. PubMed ID: 18243164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurokinin-1 receptor localisation in guinea pig autonomic ganglia.
    Messenger JP; Anderson RL; Gibbins IL
    J Comp Neurol; 1999 Oct; 412(4):693-704. PubMed ID: 10464364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the neurokinin 1 receptor in the mouse retina.
    Catalani E; Gangitano C; Bosco L; Casini G
    Neuroscience; 2004; 128(3):519-30. PubMed ID: 15381281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study.
    Invernizzi RW; Pierucci M; Calcagno E; Di Giovanni G; Di Matteo V; Benigno A; Esposito E
    Neuroscience; 2007 Feb; 144(4):1523-35. PubMed ID: 17161544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between neurokinin-1 receptor and substance P in the striatum: light and electron microscopic immunohistochemical study in the rat.
    Li JL; Wang D; Kaneko T; Shigemoto R; Nomura S; Mizuno N
    J Comp Neurol; 2000 Mar; 418(2):156-63. PubMed ID: 10701441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple striatal representation in primate substantia nigra.
    Parent A; Hazrati LN
    J Comp Neurol; 1994 Jun; 344(2):305-20. PubMed ID: 7915728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Lindefors N; Persson H; Ungerstedt U
    Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.